Riskpilot← Back to searchSign inGet full accessAasa Health AB
ABActiveOrg 5591167936Ola Hanssonsgatan 4 Lgh 1004.Computer programming activities · NACE 6210Est. 20175-9 employees
Revenue 2025
SEK 479K
+28% vs 2024
EBITDA margin
-1444.6%
+24% vs 2024
Equity ratio
-21.6%
Financial strength
Net profit 2025
SEK -6,8M
+25% vs 2024
| Revenue | SEK 479K | +28% |
| EBITDA | SEK -6,9M | +24% |
| Net profit | SEK -6,8M | +25% |
| Total assets | SEK 816K | -89% |
| Equity | SEK -176K | -103% |
| Employees | — | — |
Legal name
Aasa Health AB
Org number
5591167936
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
26 juni 2017
Share capital
SEK 110 400
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder Styrelsen ska bestå av 6 styrelseledamöter och 3 styrelsesuppleanter.
Company purpose
Bolagets verksamhet skall vara att bedriva tjänster inom medicin och läkarvetenskap, rehabilitering och utbildning samt bedriva därmed förenlig verksamhet.
Address
Ola Hanssonsgatan 4 Lgh 1004.
Email
petter@vitala.health
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 113 | 386 | 365 | 374 | 479 |
| Staff expenses | — | — | −2 638 | −4 728 | −4 994 |
| EBITDA | −1 233 | −2 519 | −8 349 | −9 162 | −6 919 |
| Depreciation & amort. | −22 | −0 | — | — | — |
| EBIT | −1 255 | −2 519 | −8 349 | −9 162 | −6 919 |
| Net financials | −1 | — | 8 | 110 | 118 |
| Profit before tax | −1 255 | −2 519 | −8 341 | −9 051 | −6 801 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −1 255 | −2 519 | −8 341 | −9 051 | −6 801 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 037 | 10 124 | 1 877 | 7 291 | 816 |
| Equity | 1 951 | 9 893 | 1 552 | 6 625 | −176 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 86 | 231 | 326 | 666 | 993 |
| Total debt | 86 | 231 | 326 | 666 | 993 |
EBITDA margin
-1444.6%
This company
15.8%
Market median
-9243% vs market
20212025
Equity ratio
-21.6%
This company
38.2%
Market median
-157% vs market
20212025
Return on equity
-680113700.0%
This company
18.4%
Market median
-3696270209% vs market
20212025
Net profit margin
-1419.9%
This company
8.1%
Market median
-17630% vs market
20212025
Asset turnover
0.59×
This company
1.12×
Market median
-47% vs market
20212025
Debt / equity
5.63×
This company
0.62×
Market median
-808% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
BP Chief Executive Officer | Chief Executive Officer | 2021 |
NH | Audit | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (8) | ||
| Chairman | 2025 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Board of Directors | 2024 | |
| Deputy Board Member | 2021 | |
| Board of Directors | 2025 | |
| Former (8) | ||
| Deputy Board Member | 2021 – 2025 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2021 – 2024 | |
| Board of Directors | 2025 – 2026 | |
| Deputy Board Member | 2021 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aasa Health AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Petter Aasa | Chief Executive Officer | 0 companies |
| Nils Hans Erik Nilsson | Audit | 0 companies |
| Karl Erik Viktor Gällström | Deputy Board Member | 0 companies |
| Henrik Oskar Andreas Wimelius | Board of Directors | 0 companies |
| Charlotta Elisabet Gummesson | Chairman | 0 companies |
| Olov Mattias Eriksson | Board of Directors | 0 companies |
| Anna Ulrika Elisabet Aasa | Board of Directors | 0 companies |
| Karl Jesper Aasa | Board of Directors | 0 companies |
| Isabel Keulen | Board of Directors | 0 companies |
| Maria Micaelsdotter Bergsten | Deputy Board Member | 0 companies |
| Johan Åke Gunnar Bloom | Board of Directors | 0 companies |
| Björn Aasa | Board of Directors | 0 companies |
| Kristaps Prusis | Deputy Board Member | 0 companies |
| Jonathan Jossi Ilicki | Board of Directors | 0 companies |
| Karl Erik Wenngren | Deputy Board Member | 0 companies |
| Mikaela Irene Pedersen | Board of Directors | 0 companies |
| Mads Mikkelsen | Board of Directors | 0 companies |
| Nils Erik Martin Gunhaga | Deputy Board Member | 0 companies |